VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.370
-0.004 (-1.12%)
At close: Dec 5, 2025, 4:00 PM EST
0.366
-0.004 (-1.19%)
After-hours: Dec 5, 2025, 7:38 PM EST
VYNE Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -33.67 | -39.83 | -28.45 | -23.21 | -73.33 | -255.57 | |
| Depreciation & Amortization | 0.02 | 0 | - | 0.07 | 0.11 | 0.34 | |
| Loss (Gain) From Sale of Assets | - | - | - | 0.28 | 0.09 | 2.1 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 54.35 | |
| Loss (Gain) From Sale of Investments | -1.23 | -2.44 | -0.26 | - | - | -0.14 | |
| Stock-Based Compensation | 2.48 | 3.3 | 3.31 | 4.3 | 8.08 | 18.1 | |
| Other Operating Activities | -0 | -0 | 0 | - | 3.9 | 84.07 | |
| Change in Accounts Receivable | 2.63 | -0.9 | 0.41 | 11.21 | 7.71 | -17.14 | |
| Change in Inventory | - | - | - | 0.1 | 0.11 | -6.05 | |
| Change in Accounts Payable | -8.46 | 6.01 | -0.56 | -8.68 | -2.68 | -12.98 | |
| Change in Other Net Operating Assets | -0.12 | -0.11 | 0.21 | -0.35 | -0.37 | -4.17 | |
| Operating Cash Flow | -38.36 | -33.97 | -25.34 | -29.2 | -56.37 | -137.08 | |
| Capital Expenditures | -0.12 | -0.12 | - | - | - | -0.11 | |
| Cash Acquisitions | - | - | - | - | - | 38.64 | |
| Investment in Securities | 41.76 | 23.48 | -62.35 | - | 1.03 | 50.58 | |
| Other Investing Activities | - | - | 5 | 15.67 | - | - | |
| Investing Cash Flow | 41.65 | 23.37 | -57.35 | 15.67 | 1.03 | 89.11 | |
| Long-Term Debt Repaid | - | - | - | - | -36.43 | - | |
| Net Debt Issued (Repaid) | - | - | - | - | -36.43 | - | |
| Issuance of Common Stock | - | - | 82.82 | 1.47 | 76.5 | 61.95 | |
| Repurchase of Common Stock | -0.26 | -0.14 | -0.07 | -0.03 | -0.29 | -0.14 | |
| Financing Cash Flow | -0.26 | -0.14 | 82.39 | 1.65 | 39.78 | 61.81 | |
| Foreign Exchange Rate Adjustments | - | - | - | - | - | 0 | |
| Net Cash Flow | 3.03 | -10.75 | -0.3 | -11.88 | -15.56 | 13.83 | |
| Free Cash Flow | -38.48 | -34.09 | -25.34 | -29.2 | -56.37 | -137.2 | |
| Free Cash Flow Margin | -7342.75% | -6804.19% | -5976.65% | -6121.59% | -6054.46% | -653.53% | |
| Free Cash Flow Per Share | -0.90 | -0.80 | -2.47 | -9.16 | -19.72 | -76.18 | |
| Cash Interest Paid | - | - | - | - | 2.39 | 3.94 | |
| Levered Free Cash Flow | -29.26 | -17 | -12.25 | -11.86 | -15.97 | -86.93 | |
| Unlevered Free Cash Flow | -29.26 | -17 | -12.25 | -11.86 | -12.47 | -84.18 | |
| Change in Working Capital | -5.96 | 5 | 0.06 | 2.28 | 4.78 | -40.33 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.